To the Editor,

We would like to thank the authors for their interest in our paper and their comments regarding our case report entitled "Coil embolization of iatrogenic coronary-pulmonary arterial fistula after heart transplantation" published in Anatol J Cardiol 2015; 15: 587-8 ([@ref1]).

The selection of the technique and devices depends on anatomic features and the characteristics of coronary artery fistulas (CAF) such as multiple fistula drainage sites and vessel tortuosity ([@ref2]). As the authors mentioned, the balloon test occlusion might be performed in selected patients with a small right coronary artery (RCA) ([@ref3]). However, RCA in our case was \> 2 mm in size.

Amplatzer vascular plugs are ideally recommended in extra-cardiac medium to large vessels with high flow and also in closing intracardiac defects including CAF in an off-label fashion ([@ref4]). Despite the advantages of being safe and cost-effective, the Amplatzer vascular plug was not used in our case on the basis of these reasons. Additionally, one of the indications for the preference of graft stents is coronary fistula sealing following coil embolization, as seen in our case ([@ref5]).

Hemodynamic extracorporeal membrane oxygenation (ECMO) support is recommended in patients with low systolic ejection fraction undergoing high-risk cardiovascular surgery. However, our patient had normal left and right systolic ejection fractions and underwent low-risk percutaneous cardiovascular intervention. This is the reason why the ECMO support was not used in our patient ([@ref6]).
